ArticleNature communications2022

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.

Shivam Rai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.